Streetbeat News

Earnings

CMCSA

Comcast shares are trading lower following the release of their Q1 earnings.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:06 pm

NEM

Newmont Corporation's shares saw an increase following the announcement of their Q1 2024 earnings, which surpassed analysts' expectations in terms of adjusted EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:05 pm

BSPK

GCTK

TGEN

Insiders at Tecogen Inc., Bespoke Extracts Inc., and GlucoTrack Inc. have recently made significant purchases of their companies' stocks, signaling potential confidence in their respective companies' futures. Tecogen is poised to release its Q1 financial results, Bespoke Extracts has seen a 22% stock decline over six months, and GlucoTrack announced the closing of a private placement.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:03 pm

AXP

BCS

SLM

As of April 25, 2024, Barclays PLC (BCS), SLM Corporation (SLM), and American Express Company (AXP) are identified as overbought financial stocks, potentially signaling a short-term performance warning. BCS, SLM, and AXP have shown significant gains, with their RSI values indicating they are overbought. This could suggest a cautionary outlook for momentum investors in these stocks.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:03 pm

AZN

AstraZeneca Plc (NASDAQ:AZN) reported Q1 sales of $12.68 billion, a 17% increase year over year, driven by strong sales in cancer drugs, but missed the adjusted EPADS consensus. The company saw an 18% increase in Product Sales and growth in Alliance Revenue. R&D expenses rose to $2.7 billion, with sales and administration costs up due to marketing for new drugs. Oncology sales jumped 26% to $5.12 billion, with Tagrisso and Imfinzi leading. CVRM sales increased 20%, and Rare Disease drug sales were up 12%. AstraZeneca reaffirmed its fiscal year 2024 guidance for revenue and core EPS to increase by a low double-digit to low teens percentage. AZN shares were up 4.99% at $74.75 in the premarket session.

Portfolio Pulse from Vandana Singh

April 25, 2024 | 1:03 pm

BMY

Bristol-Myers Squibb's stock price has decreased following the release of their Q1 earnings report.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:02 pm

JMSB

John Marshall Bancorp (JMSB) reported a 31.82% decrease in Q1 earnings per share, dropping to $0.30 from $0.44 YoY.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:01 pm

CMG

Chipotle Mexican Grill, Inc. (NYSE:CMG) reported Q1 financial results surpassing expectations with a 14.1% revenue increase to $2.702 billion and adjusted earnings of $13.37 per share. Comparable restaurant sales grew by 7%. The company anticipates mid- to high-single-digit sales growth and plans to open 285 to 315 new restaurants in 2024. Following the announcement, analysts raised their price targets for CMG, reflecting optimism about the company's growth prospects.

Portfolio Pulse from Avi Kapoor

April 25, 2024 | 1:01 pm

CLIA

SEMI

STM

STMicroelectronics NV (STM) reported a significant decline in Q1 revenue and earnings, missing consensus estimates. The company saw decreases across all product segments, leading to a lowered annual outlook for 2024. Despite these challenges, STM shares rose 1.50% in premarket trading. Investors can also gain exposure to STM through ETFs like CLIA and SEMI.

Portfolio Pulse from Anusuya Lahiri

April 25, 2024 | 12:59 pm

CMCSA

Comcast Corp (NASDAQ:CMCSA) reported Q1 earnings with a revenue increase of 1.2% YoY to $30.058 billion, surpassing estimates. EPS was $1.04, beating the 99 cents forecast. Peacock subscribers rose 55% YoY to 34 million. Despite positive results, CMCSA shares fell 3.62% to $38.76.

Portfolio Pulse from Adam Eckert

April 25, 2024 | 12:57 pm